Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Aliskiren is a novel renin-angiotensin aldosterone system (RAAS) inhibitor, the combination therapy of aliskiren and amlodipine for blood pressure control have been reported recently. The primary objective of this analysis is to review recently reported randomized controlled trials (RCTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yukai, Chen, Ken, Kou, Xun, Han, Yu, Zhou, Lin, Zeng, Chunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726495/
https://www.ncbi.nlm.nih.gov/pubmed/23922924
http://dx.doi.org/10.1371/journal.pone.0070111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726495/
https://www.ncbi.nlm.nih.gov/pubmed/23922924
http://dx.doi.org/10.1371/journal.pone.0070111

Ejemplares similares